The tolerance and antidepressive activity of fluvoxamine as a single dose compared to a twice daily dose

References

• Claassen V. Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br. J. Clin. Pharmacol. 1983; 15: 349S–355S1. Claassen V. Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br. J. Clin. Pharmacol. 1983; 15: 349S–355S
   PubMed Web of Science ®Google Scholar
• Claassen V., Coleman B. S., Koopman T. M. S., Post L. C., Sharp D., Vrijbergen A. G., Wakelin J. S. Summary of the properties of fluvoxamine maleate. 1982, Duphar Report No. 56681.081.82.2. Claassen V., Coleman B. S., Koopman T. M. S., Post L. C., Sharp D., Vrijbergen A. G., Wakelin J. S. Summary of the properties of fluvoxamine maleate. 1982, Duphar Report No. 56681.081.82.
   Google Scholar
• Claassen V., Davies J. E., Hertting G., Placheta P. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br. J. Pharmacol. 1977; 60: 505–5163. Claassen V., Davies J. E., Hertting G., Placheta P. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br. J. Pharmacol. 1977; 60: 505–516
   PubMed Web of Science ®Google Scholar
• Coleman B. S., Block B. A. Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine. Prog. Neuro-psychopharmacol. 1982; 6: 475–4784. Coleman B. S., Block B. A. Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine. Prog. Neuro-psychopharmacol. 1982; 6: 475–478
   PubMed Web of Science ®Google Scholar
• deBree H., Schoot van der J. B., Post L. C. Fluvoxamine maleate; disposition in man. Eur. J. Drug Metabol. Pharmacokinet. 1983; 8: 175–1795. deBree H., Schoot van der J. B., Post L. C. Fluvoxamine maleate; disposition in man. Eur. J. Drug Metabol. Pharmacokinet. 1983; 8: 175–179
   Web of Science ®Google Scholar
• De Wilde J. E., Mertens C., Wakelin J. S. Clinical trials of fluvoxamine vs chlorimipramine with a single and three times daily dosing. Br. J. Clin. Pharmacol. 1983; 15: 427S–431S6. De Wilde J. E., Mertens C., Wakelin J. S. Clinical trials of fluvoxamine vs chlorimipramine with a single and three times daily dosing. Br. J. Clin. Pharmacol. 1983; 15: 427S–431S
   PubMed Web of Science ®Google Scholar
• Feighner J. P., Robins E., Guze S. B., Woodruff R. A., Winokur G., Munoz R. Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry 1978; 26: 57–637. Feighner J. P., Robins E., Guze S. B., Woodruff R. A., Winokur G., Munoz R. Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry 1978; 26: 57–63
   Google Scholar
• Guelfi J. D., Dreyfus F. Fluvoxamine: efficacy and tolerance of a new antidepressant in a large multicentre study. Clin. Neuropharmacol. 1984; 7(Suppl. 1)582–5838. Guelfi J. D., Dreyfus F. Fluvoxamine: efficacy and tolerance of a new antidepressant in a large multicentre study. Clin. Neuropharmacol. 1984; 7(Suppl. 1)582–583
   Google Scholar
• Guelfi J. D., Dreyfus J. F., Pichot P. G.E.P.E.C.E.P. A double-blind controlled clinical trial comparing fluvoxamine with imipramine. Br. J. Clin. Pharmacol. 1983; 15: 411S–417S9. Guelfi J. D., Dreyfus J. F., Pichot P. G.E.P.E.C.E.P. A double-blind controlled clinical trial comparing fluvoxamine with imipramine. Br. J. Clin. Pharmacol. 1983; 15: 411S–417S
   Web of Science ®Google Scholar
• Guy W. Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health, Rockville, MD. 1976; 217–22210. Guy W. Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health, RockvilleMD. 1976; 217–222
   Google Scholar
• Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967; 6: 278–29611. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967; 6: 278–296
   PubMed Web of Science ®Google Scholar
• Itil T. M., Shrivastava R. V., Mukherjee S., Coleman B., Michael S. T. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression. Br. J. Clin. Pharmacol. 1983; 15: 433S–438S12. Itil T. M., Shrivastava R. V., Mukherjee S., Coleman B., Michael S. T. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression. Br. J. Clin. Pharmacol. 1983; 15: 433S–438S
   PubMed Web of Science ®Google Scholar
• Klok C. J., Brouwer G. J., van Praag H. M., Doogan D. Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr. Scand. 1981; 64: 1–1113. Klok C. J., Brouwer G. J., van Praag H. M., Doogan D. Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr. Scand. 1981; 64: 1–11
   PubMed Web of Science ®Google Scholar
• Montgomery S. A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatr. 1979; 134: 382–38914. Montgomery S. A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatr. 1979; 134: 382–389
   PubMed Web of Science ®Google Scholar
• Overmars H., Scherpenisse P. M., Post L. C. Fluvoxamine maleate; metabolism in man. Eur. J. Drug Metabol. Pharmacokinet. 1983; 8: 269–28015. Overmars H., Scherpenisse P. M., Post L. C. Fluvoxamine maleate; metabolism in man. Eur. J. Drug Metabol. Pharmacokinet. 1983; 8: 269–280
   PubMed Web of Science ®Google Scholar
• Van der Schoot J. B., de Bree H., van Amsterdam H., Sharp D., Winsemius A. A., van Bemmel P. Plasma levels of fluvoxamine after multiple oral administration of fluvoxamine maleate to healthy volunteers. 1983, Duphar Report No. H. 114.618.16. Van der Schoot J. B., de Bree H., van Amsterdam H., Sharp D., Winsemius A. A., van Bemmel P. Plasma levels of fluvoxamine after multiple oral administration of fluvoxamine maleate to healthy volunteers. 1983, Duphar Report No. H. 114.618.
   Google Scholar
• Van der Schoot J. B., de Bree H., van Amsterdam P. H., Sharp D. J., Winsemius A. A. Plasma levels of fluvoxamine after multiple oral administration of fluvoxamine maleate to depressed patients. 1983, Duphar Report No. H. 114.619.17. Van der Schoot J. B., de Bree H., van Amsterdam P. H., Sharp D. J., Winsemius A. A. Plasma levels of fluvoxamine after multiple oral administration of fluvoxamine maleate to depressed patients. 1983, Duphar Report No. H. 114.619.
   Google Scholar
• Watson J. M., Tiplady B. Zimelidine: comparison of different dosage regimens in general practice. Acta Psychiatr. Scand. 1981; 63(Suppl. 290)64–7018. Watson J. M., Tiplady B. Zimelidine: comparison of different dosage regimens in general practice. Acta Psychiatr. Scand. 1981; 63(Suppl. 290)64–70
   Google Scholar
• Weise C. C., Stein M. K., Pereira-Organ J., Csanalosi I., Rickels K. Amitriptyline once daily vs three times daily in depressed out-patients. Arch. Gen. Psychiatry 1980; 37: 555–56019. Weise C. C., Stein M. K., Pereira-Organ J., Csanalosi I., Rickels K. Amitriptyline once daily vs three times daily in depressed out-patients. Arch. Gen. Psychiatry 1980; 37: 555–560
   PubMed Web of Science ®Google Scholar
• Wheatley D. The side-effects profile of new antidepressants. “New Directions in Antidepressant Therapy. An International Review of Triazolopyradine Derivatives”. R. Soc. Med., Int. Congr. Symp. Ser. Academic Press, London 1982; 87–9320. Wheatley D. The side-effects profile of new antidepressants. “New Directions in Antidepressant Therapy. An International Review of Triazolopyradine Derivatives”. R. Soc. Med., Int. Congr. Symp. Ser. Academic Press, London 1982; 87–93
   Google Scholar